Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

MyDx Introduces the Eco Smart Pen
Biotechnology

MyDx Introduces the Eco Smart Pen

April 25, 2017 9:30 AM

The Next Level of Public Safety & Transparency for the Cannabis Industry SAN DIEGO, CA / ACCESSWIRE / April 25, 2017 / MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments it alleviates, today announced its...

Read more
MorphoSys to Host Q1 2017 Conference Call on May 3, 2017
BiotechnologyInterim Report

MorphoSys to Host Q1 2017 Conference Call on May 3, 2017

April 24, 2017 9:25 AM

MUNICH, GERMANY / ACCESSWIRE / April 24, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) will publish its first three months' 2017 results on May 3, 2017 at 7:00 am CEST. At 3:00 pm CEST (2:00 pm BST, 9:00 am EDT), the Management Board of MorphoSys AG will host a public conference call and webcast to present MorphoSys's first quarter interim statement 2017 and provide further details on the Company's latest...

Read more
Alliance Bio-Products, Inc. to Present at the Planet MicroCap Showcase 2017
BiotechnologyConferences

Alliance Bio-Products, Inc. to Present at the Planet MicroCap Showcase 2017

April 24, 2017 9:15 AM

WEST PALM BEACH, FL / ACCESSWIRE / April 24, 2017 / Alliance Bio-Products, Inc. (Bio-Products), a subsidiary of Alliance BioEnergy Plus, Inc. (OTCQB: ALLM), today announced that it will be presenting at the inaugural Planet MicroCap Showcase being held from April 26-28, 2017 at the Planet Hollywood Resort & Casino in Las Vegas, NV. Daniel de Liege, Chairman of Alliance Bio-Products, will be presenting at 11:30 a.m. PT on Thursday, April 27th....

Read more
Kineta to Present at the Planet MicroCap Showcase 2017
BiotechnologyConferences

Kineta to Present at the Planet MicroCap Showcase 2017

April 21, 2017 8:00 AM

SEATTLE, WA / ACCESSWIRE / April 21, 2017 / Kineta, Inc., a biotechnology company focused on the development of novel immuno-therapies, today announced the company has been invited to present at the inaugural Planet MicroCap Showcase being held on April 26-28, 2017 at the Planet Hollywood Resort & Casino in Las Vegas, NV. Kineta will be presenting at 1:30 PM EDT/ 10:30 AM PDT on April 27, 2017. Rob Hedequist, President and COO, will provide an...

Read more
United Cannabis Corporation Enters Strategic Partnership with Advesa to Accelerate California Expansion
Biotechnology

United Cannabis Corporation Enters Strategic Partnership with Advesa to Accelerate California Expansion

April 20, 2017 12:45 PM

Flagship Lab Will Serve as Company's Primary Production and Distribution Facility to Manage Increased Demand Across California DENVER, CO / ACCESSWIRE / April 20, 2017 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that it has entered into a Strategic Partnership with Advesa, a California Corporation ("Advesa"), to serve as its flagship product manufacturing facility in California for United...

Read more
Clinical Sensors Awarded Over $1.5M in NIH Grants to Advance its Nitric Oxide Diagnostic for Sepsis Recognition and Management
Biotechnology

Clinical Sensors Awarded Over $1.5M in NIH Grants to Advance its Nitric Oxide Diagnostic for Sepsis Recognition and Management

April 18, 2017 7:55 AM

RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 18, 2017 / Clinical Sensors, Inc. announced today that it was awarded two Small Business Research Grants from the National Institutes of Health (NIH). Together, these grants provide over $1.5 million to support the company's continued development and demonstration of its point-of-care device that directly measures a patient's blood nitric oxide level within a few seconds. Nitric oxide is involved...

Read more
MorphoSys to Present at Upcoming Conferences
BiotechnologyConference

MorphoSys to Present at Upcoming Conferences

April 11, 2017 8:30 AM

PLANEGG / MUNICH, GERMANY / ACCESSWIRE / April 11, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) will present at the following conferences: 10th Kempen Life Sciences Conference Date: April 19, 2017 Venue: Amsterdam, Netherlands Presenter: Jens Holstein, Chief Financial Officer of MorphoSys AG UBS Global Healthcare Conference Date: May 22/23, 2017 Venue: New York, NY, USA Presenter: Dr. Simon...

Read more
Abattis Bioceuticals Announces New CEO
Biotechnology

Abattis Bioceuticals Announces New CEO

April 10, 2017 10:10 AM

VANCOUVER, BC / ACCESSWIRE / April 10, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company. Mr. Abenante is a seasoned executive with extensive public company experience. Mr. Abenante is a Chartered Professional Accountant (CPA, CA) who also holds a Masters. After his tenures with...

Read more
MYDX Achieves 40,000+ Consumer-Generated Pre-Clinical Data Points Growing at 100% Year Over Year
Biotechnology

MYDX Achieves 40,000+ Consumer-Generated Pre-Clinical Data Points Growing at 100% Year Over Year

April 7, 2017 3:40 PM

Smart Devices Solidify the Critical Need for Community Participation in Generating Big Data and Formulating Cannabis Therapeutics SAN DIEGO, CA / ACCESSWIRE / April 7, 2017 / MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for the Cannabis professional and retail consumer to correlate the chemical profile of cannabis with how it makes...

Read more
MorphoSys Nominates New Candidate for Supervisory Board
BiotechnologyChange of PersonnelMiscellaneous

MorphoSys Nominates New Candidate for Supervisory Board

April 3, 2017 2:00 AM

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 3, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that it has published its agenda for the Company's ordinary Annual General Meeting (AGM), which will take place on Wednesday, May 17, 2017. MorphoSys's Supervisory Board has nominated Krisja Vermeylen as candidate to be elected as a new Supervisory Board member at the Company's AGM. Ms. Vermeylen will...

Read more
Vitro Biopharma Receives Funding to Expand its Stem Cell Therapies
Biotechnology

Vitro Biopharma Receives Funding to Expand its Stem Cell Therapies

March 29, 2017 9:30 AM

GOLDEN, CO / ACCESSWIRE / March 29, 2017 / Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro Biopharma, announced the completion of a bridge loan in the amount of $125,000 and the execution of a Memorandum of Understanding ("MOU") outlining the terms of a larger, subsequent financing to provide a total of not less than $1.7 million. Completion of the subsequent larger financing through the execution of a definitive agreement would initiate the...

Read more
Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month
Biotechnology

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month

March 27, 2017 2:09 PM

VANCOUVER, BC / ACCESSWIRE / March 27, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government's upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018. As reported by the CBC, Trudeau's government will follow the recommendations of a...

Read more
MorphoSys's CSO Marlies Sproll Takes Temporary Leave, Markus Enzelberger to Serve as Interim CSO
BiotechnologyMiscellaneous

MorphoSys's CSO Marlies Sproll Takes Temporary Leave, Markus Enzelberger to Serve as Interim CSO

March 23, 2017 3:00 AM

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 23, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY), a leader in the field of therapeutic antibodies, today announced that Dr. Marlies Sproll, the Company's long-standing Chief Scientific Officer, will be on temporary leave from her CSO position for family matters as of April 15, 2017. Dr. Sproll will take leave of absence from her function as member of the Executive Board...

Read more
Vitality Biopharma to Present at The MicroCap Conference on April 4th in New York City at the Essex House
Biotechnology

Vitality Biopharma to Present at The MicroCap Conference on April 4th in New York City at the Essex House

March 20, 2017 1:48 PM

LOS ANGELES, CA / ACCESSWIRE / March 20, 2017 / Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, will be presenting at this year's MicroCap Conference on April 4th in New York City at the Essex House. The MicroCap Conference is an...

Read more
Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine
Biotechnology

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine

March 20, 2017 11:53 AM

VANCOUVER, BC / ACCESSWIRE / March 20, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine's Science Advisory efforts. Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned expert in the formulation and commercialization of botanical-based products, with a focus on...

Read more
Frank E. Celli, CEO of BioHiTech Global (OTCQB: BHTG), to Present at The MicroCap Conference on April 4th at 9:00 AM ET in New York City at the Essex House
Biotechnology

Frank E. Celli, CEO of BioHiTech Global (OTCQB: BHTG), to Present at The MicroCap Conference on April 4th at 9:00 AM ET in New York City at the Essex House

March 17, 2017 10:56 AM

NEW YORK, NY / ACCESSWIRE / March 17, 2017 / BioHiTech Global (OTCQB: BHTG) CEO, Frank E. Celli, will be a featured presenter at the MicroCap Conference on April 4th in New York City, sponsored by The Special Equities Group and Maxim Group. Management will be available for one-on-one investor meetings throughout the conference. CONFERENCE OVERVIEW AND STRUCTURE The MicroCap Conference is an exclusive event for investors who specialize in small...

Read more
Applied DNA Sciences, Inc. to Present at The MicroCap Conference on April 4th in New York City at the Essex House
Biotechnology

Applied DNA Sciences, Inc. to Present at The MicroCap Conference on April 4th in New York City at the Essex House

March 16, 2017 3:35 PM

NEW YORK, NY / ACCESSWIRE / March 16, 2017 / Applied DNA Sciences, Inc. (NASDAQ: APDN) will be presenting at this year's The MicroCap Conference on April 4th in New York City, sponsored by The Special Equities Group and Maxim Group. CONFERENCE OVERVIEW AND STRUCTURE The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at...

Read more
Mount TAM Biotechnologies, Inc. to Present at The MicroCap Conference on April 4th in New York City at the Essex House
Biotechnology

Mount TAM Biotechnologies, Inc. to Present at The MicroCap Conference on April 4th in New York City at the Essex House

March 16, 2017 3:29 PM

NEW YORK, NY / ACCESSWIRE / March 16, 2017 / Mount TAM Biotechnologies, Inc. (OTC PINK: MNTM) will be presenting at this year's The MicroCap Conference on April 4th in New York City, sponsored by The Special Equities Group and Maxim Group. CONFERENCE OVERVIEW AND STRUCTURE The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management...

Read more
Abattis Team Positions for Next Stage of Growth
Biotechnology

Abattis Team Positions for Next Stage of Growth

March 13, 2017 9:19 AM

VANCOUVER, BC / ACCESSWIRE / March 13, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs, and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern Vine Labs continues, more key management hires and appointments will accompany this next stage...

Read more
Cell MedX Corp. Announces First Subjects Screened and Qualified for the Observational Clinical Trial
Biotechnology

Cell MedX Corp. Announces First Subjects Screened and Qualified for the Observational Clinical Trial

March 9, 2017 8:09 AM

CARSON CITY, NV / ACCESSWIRE / March 9, 2017 / Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), is pleased to announce that Dr. Richard Tytus, the Lead Investigator on the previously announced Observational Clinical Trial (the "Trial"), and his team at Hamilton Medical Research Group have commenced screening for qualified subjects. The group of seven potential study participants have been screened with an additional five subjects...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?